Cargando…
Synthesis of “All-Cis” Trihydroxypiperidines from a Carbohydrate-Derived Ketone: Hints for the Design of New β-Gal and GCase Inhibitors
Pharmacological chaperones (PCs) are small compounds able to rescue the activity of mutated lysosomal enzymes when used at subinhibitory concentrations. Nitrogen-containing glycomimetics such as aza- or iminosugars are known to behave as PCs for lysosomal storage disorders (LSDs). As part of our res...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7582770/ https://www.ncbi.nlm.nih.gov/pubmed/33023214 http://dx.doi.org/10.3390/molecules25194526 |
_version_ | 1783599268194418688 |
---|---|
author | Davighi, Maria Giulia Clemente, Francesca Matassini, Camilla Morrone, Amelia Goti, Andrea Martínez-Bailén, Macarena Cardona, Francesca |
author_facet | Davighi, Maria Giulia Clemente, Francesca Matassini, Camilla Morrone, Amelia Goti, Andrea Martínez-Bailén, Macarena Cardona, Francesca |
author_sort | Davighi, Maria Giulia |
collection | PubMed |
description | Pharmacological chaperones (PCs) are small compounds able to rescue the activity of mutated lysosomal enzymes when used at subinhibitory concentrations. Nitrogen-containing glycomimetics such as aza- or iminosugars are known to behave as PCs for lysosomal storage disorders (LSDs). As part of our research into lysosomal sphingolipidoses inhibitors and looking in particular for new β-galactosidase inhibitors, we report the synthesis of a series of alkylated azasugars with a relative “all-cis” configuration at the hydroxy/amine-substituted stereocenters. The novel compounds were synthesized from a common carbohydrate-derived piperidinone intermediate 8, through reductive amination or alkylation of the derived alcohol. In addition, the reaction of ketone 8 with several lithium acetylides allowed the stereoselective synthesis of new azasugars alkylated at C-3. The activity of the new compounds towards lysosomal β-galactosidase was negligible, showing that the presence of an alkyl chain in this position is detrimental to inhibitory activity. Interestingly, 9, 10, and 12 behave as good inhibitors of lysosomal β-glucosidase (GCase) (IC(50) = 12, 6.4, and 60 µM, respectively). When tested on cell lines bearing the Gaucher mutation, they did not impart any enzyme rescue. However, altogether, the data included in this work give interesting hints for the design of novel inhibitors. |
format | Online Article Text |
id | pubmed-7582770 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-75827702020-10-28 Synthesis of “All-Cis” Trihydroxypiperidines from a Carbohydrate-Derived Ketone: Hints for the Design of New β-Gal and GCase Inhibitors Davighi, Maria Giulia Clemente, Francesca Matassini, Camilla Morrone, Amelia Goti, Andrea Martínez-Bailén, Macarena Cardona, Francesca Molecules Article Pharmacological chaperones (PCs) are small compounds able to rescue the activity of mutated lysosomal enzymes when used at subinhibitory concentrations. Nitrogen-containing glycomimetics such as aza- or iminosugars are known to behave as PCs for lysosomal storage disorders (LSDs). As part of our research into lysosomal sphingolipidoses inhibitors and looking in particular for new β-galactosidase inhibitors, we report the synthesis of a series of alkylated azasugars with a relative “all-cis” configuration at the hydroxy/amine-substituted stereocenters. The novel compounds were synthesized from a common carbohydrate-derived piperidinone intermediate 8, through reductive amination or alkylation of the derived alcohol. In addition, the reaction of ketone 8 with several lithium acetylides allowed the stereoselective synthesis of new azasugars alkylated at C-3. The activity of the new compounds towards lysosomal β-galactosidase was negligible, showing that the presence of an alkyl chain in this position is detrimental to inhibitory activity. Interestingly, 9, 10, and 12 behave as good inhibitors of lysosomal β-glucosidase (GCase) (IC(50) = 12, 6.4, and 60 µM, respectively). When tested on cell lines bearing the Gaucher mutation, they did not impart any enzyme rescue. However, altogether, the data included in this work give interesting hints for the design of novel inhibitors. MDPI 2020-10-02 /pmc/articles/PMC7582770/ /pubmed/33023214 http://dx.doi.org/10.3390/molecules25194526 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Davighi, Maria Giulia Clemente, Francesca Matassini, Camilla Morrone, Amelia Goti, Andrea Martínez-Bailén, Macarena Cardona, Francesca Synthesis of “All-Cis” Trihydroxypiperidines from a Carbohydrate-Derived Ketone: Hints for the Design of New β-Gal and GCase Inhibitors |
title | Synthesis of “All-Cis” Trihydroxypiperidines from a Carbohydrate-Derived Ketone: Hints for the Design of New β-Gal and GCase Inhibitors |
title_full | Synthesis of “All-Cis” Trihydroxypiperidines from a Carbohydrate-Derived Ketone: Hints for the Design of New β-Gal and GCase Inhibitors |
title_fullStr | Synthesis of “All-Cis” Trihydroxypiperidines from a Carbohydrate-Derived Ketone: Hints for the Design of New β-Gal and GCase Inhibitors |
title_full_unstemmed | Synthesis of “All-Cis” Trihydroxypiperidines from a Carbohydrate-Derived Ketone: Hints for the Design of New β-Gal and GCase Inhibitors |
title_short | Synthesis of “All-Cis” Trihydroxypiperidines from a Carbohydrate-Derived Ketone: Hints for the Design of New β-Gal and GCase Inhibitors |
title_sort | synthesis of “all-cis” trihydroxypiperidines from a carbohydrate-derived ketone: hints for the design of new β-gal and gcase inhibitors |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7582770/ https://www.ncbi.nlm.nih.gov/pubmed/33023214 http://dx.doi.org/10.3390/molecules25194526 |
work_keys_str_mv | AT davighimariagiulia synthesisofallcistrihydroxypiperidinesfromacarbohydratederivedketonehintsforthedesignofnewbgalandgcaseinhibitors AT clementefrancesca synthesisofallcistrihydroxypiperidinesfromacarbohydratederivedketonehintsforthedesignofnewbgalandgcaseinhibitors AT matassinicamilla synthesisofallcistrihydroxypiperidinesfromacarbohydratederivedketonehintsforthedesignofnewbgalandgcaseinhibitors AT morroneamelia synthesisofallcistrihydroxypiperidinesfromacarbohydratederivedketonehintsforthedesignofnewbgalandgcaseinhibitors AT gotiandrea synthesisofallcistrihydroxypiperidinesfromacarbohydratederivedketonehintsforthedesignofnewbgalandgcaseinhibitors AT martinezbailenmacarena synthesisofallcistrihydroxypiperidinesfromacarbohydratederivedketonehintsforthedesignofnewbgalandgcaseinhibitors AT cardonafrancesca synthesisofallcistrihydroxypiperidinesfromacarbohydratederivedketonehintsforthedesignofnewbgalandgcaseinhibitors |